Purpose: To evaluate the clinical characteristics of uveitis or pseudouveitis presenting de novo in Japanese elderly patients. Methods: We retrospectively examined 296 patients with uveitis or pseudouveitis who were treated at Toyama Medical and Pharmaceutical University Hospital. Patients were followed up for 1 week to 5 years (mean, 11 months). Results: Of 296 patients, 82 (38 men and 44 women, 120 eyes) presented with their first episode of uveitis or pseudouveitis at the age of ≧60 years. Forty patients had anterior uveitis, 2 had intermediate uveitis and the other 40 had posterior and/or pan-uveitis. Of 82 patients, 53 (64.6%) had idiopathic uveitis. The prevalence of Vogt-Koyanagi-Harada syndrome and Behçet disease in elderly patients was lower than that in younger patients. Complicated cataract was frequently seen in the eyes with uveitis. Most eyes with uveitis had poor visual acuity. Conclusions: The prevalence of Vogt-Koyanagi-Harada syndrome and Behçet disease in elderly patients was lower than that in younger patients.

Keywords:
Elderly, Pseudouveitis, Uveitis
1.
Darrell RW, Wagener HP, Kurland LT: Epidemiology of uveitis. Arch Ophthalmol 1962;68:502–514.
2.
Matsumoto M, Katayama T, Yamamoto S, Endo A, Hayasaka S: An eight-year review of uveitis in our institution. Rinsho Ganka 1995;49:1461–1464.
3.
Saari KM, Paivonsalo-Hietanen T, Tuominen J: Epidemiology of endogenous uveitis in south-western Finland; in Ohno S, Aoki K, Usui M, Uchio E (eds): Uveitis Today. Amsterdam, Elsevier, 1998, pp 269–272.
4.
Vassileva P: Epidemiology of uveitis in Bulgaria; in Ohno S, Aoki K, Usui M, Uchio E (eds): Uveitis Today. Amsterdam, Elsevier, 1998, pp 251–254.
5.
Barton K, Pavesio CE, Towler HMA, Lightman S: Uveitis presenting de novo in the elderly. Eye 1994;8:288–291.
6.
Chatzistefanou K, Markomichelakis NN, Christen W, Soheilian M, Foster CS: Characteristics of uveitis presenting for the first time in the elderly. Ophthalmology 1998;105:347–352.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.